Gold Silver Reports (GSR) – Biocon Rises After Bengaluru Facility Clears Regulatory Inspection – Shares of the drugmaker rose as much as 2.3 percent to Rs 644.35. – The company said that it received an Establishment Inspection Report (EIR) from the U.S. drug regulator for its manufacturing facility in Bengaluru, according to its stock exchange notification.
The stock trades at 63 times its estimated earnings per share for the coming year, Bloomberg data showed. The scrip rose 99 percent in the past 12 months.
Vakrangee jumps After Block Deals
Shares of Vakrangee rose hit its daily upper limit for the sixth day, its longest winning streak in over a week. The stock traded at Rs 55.10.
About 24 lakh shares or 0.2 percent equity changed hands in two block deals on National Stock Exchange, Bloomberg data showed. Buyers and sellers were not known immediately.
Post Updated 25 June, 2018 10:06 AM
